Credit rating agency, ICRA has assigned BBB- rating to the Rs 810.0 crore term loan facilities of Strides Arcolab. The rating agency has also assigned A3 rating to the Rs 125.0 crore short term loan facilities, Rs 250.0 crore fund based facilities and the Rs 135.0 crore non-fund based facilities of the company. The outlook on the long-term rating is stable.
The assigned ratings reflect the company’s strong focus in the niche sterile segment over the years, the traditional pharmaceutical business lending stability to revenues; its healthy track record of ANDA filings and robust product pipeline with large number of United States Food and Drug Administration (USFDA) approved products to be commercialized.
Strides Arcolab is a global pharmaceuticals company headquartered in Banglore, India that develops and manufactures wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1677.90 |
| Dr. Reddys Lab | 1230.00 |
| Cipla | 1229.00 |
| Zydus Lifesciences | 932.15 |
| Lupin | 2333.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: